These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34217140)

  • 1. What is the role of glycemic control in the development of preeclampsia among women with type 1 diabetes?
    Mecacci F; Ottanelli S; Vannuccini S; Serena C; Rambaldi MP; Simeone S; Clemenza S; Comito C; Lisi F; Mello G; Petraglia F
    Pregnancy Hypertens; 2021 Aug; 25():191-195. PubMed ID: 34217140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
    Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Wright D; Efeturk T; Ceccacci I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):367-372. PubMed ID: 28133831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of early aspirin therapy on utero-placental hemodynamics in patients at risk of preeclampsia.
    Malah N; Hofstaetter C; Raio L; Surbek D
    J Matern Fetal Neonatal Med; 2022 Jun; 35(12):2304-2310. PubMed ID: 32731776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control assessed by continuous glucose monitoring during pregnancy in women with type 1 diabetes and its association with preeclampsia, an observational Swedish cohort study.
    Englund Ögge L; Dotevall A; Elfvin A; Sandgren U; Linden K; Bohlin L; Wallstersson B; Sjödell M; Augustinsson J; Hagman A
    Acta Obstet Gynecol Scand; 2024 Jul; 103(7):1426-1436. PubMed ID: 38725185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine and umbilical artery Doppler at 28 weeks for predicting adverse pregnancy outcomes in women with abnormal uterine artery Doppler findings in the early second trimester.
    Ventura W; De Paco Matallana C; Prieto-Sanchez MT; Macizo MI; Pertegal M; Nieto A; Delgado JL
    Prenat Diagn; 2015 Mar; 35(3):294-8. PubMed ID: 25483940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine artery Doppler at 30-33 weeks' gestation in the prediction of preeclampsia.
    Lai J; Poon LC; Pinas A; Bakalis S; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):156-63. PubMed ID: 23445882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of preeclampsia in women with type 1 diabetes.
    Gutaj P; Zawiejska A; Mantaj U; Wender-Ożegowska E
    Acta Diabetol; 2017 Dec; 54(12):1115-1121. PubMed ID: 28975446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal cardiac function at 19-23 weeks' gestation in prediction of pre-eclampsia.
    Gibbone E; Wright A; Vallenas Campos R; Sanchez Sierra A; Nicolaides KH; Charakida M
    Ultrasound Obstet Gynecol; 2021 May; 57(5):739-747. PubMed ID: 33294998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation.
    Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Apr; 57(4):600-606. PubMed ID: 33073902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks' gestation.
    Gallo DM; Poon LC; Akolekar R; Syngelaki A; Nicolaides KH
    Fetal Diagn Ther; 2013; 34(4):241-7. PubMed ID: 24192614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised uterine artery impedance is associated with increased maternal arterial stiffness in the late second trimester.
    Everett TR; Mahendru AA; McEniery CM; Wilkinson IB; Lees CC
    Placenta; 2012 Jul; 33(7):572-7. PubMed ID: 22538229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of sequential models of uterine artery Doppler in pregnancies at high risk for pre-eclampsia.
    Herraiz I; Escribano D; Gómez-Arriaga PI; Herníndez-García JM; Herraiz MA; Galindo A
    Ultrasound Obstet Gynecol; 2012 Jul; 40(1):68-74. PubMed ID: 22102516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.